Eliminating the cost barrier to preventive services such as GDM screening during pregnancy will helpmore women receive this important service, both because of affordability and because the message it sends to practitioners about the importance
of testing pregnant women for GDM and type 2 diabetes. The result will be seen in more women with GDM and/or type 2 diabetes receiving the care they need to reduce the risk of costly complications, including preeclampsia,birth injury, and neonatal hypoglycemia in the short term and the long-term risk of diabetes for both mothers and their children.